Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The Age-Related Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion by 2029, growing from USD 10.46 Billion in 2024, at a CAGR of ...